Preclinical investigations of IMU-838, an orally available small molecule inhibitor of Dihydroorotate Dehydrogenase for the treatment of inflammatory bowel disease

(1) Immunic AG,Planegg-Martinsried,Germany

This item was part of the IBD II (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019